American Health Council Names Jaime Steinsapir, M.D., PhD, FACP, FACE to Physician Board

NEW YORK, May 23, 2017 (GLOBE NEWSWIRE) -- Dr. Jaime Steinsapir, Endocrinologist at Palm Beach Diabetes and Endocrine Specialists, PA has been selected to join the Physician Board at the American Health Council. He will be sharing his knowledge and expertise in Thyroid Disease and Diabetes.

Amassing over four decades in the field, Dr. Steinsapir excels in his current role as an Endocrinologist at Palm Beach Diabetes and Endocrine Specialists, PA. Serving multiple locations in Florida, Palm Beach Diabetes and Endocrine Specialists, PA is a pioneer in the fight against diabetes and other endocrine disorders, through patient education, goal setting, and individual involvement in a personalized treatment program. Each board-certified physician has extensive clinical practice, research, and teaching experience in endocrinology, diabetes and metabolism.

Board Certified in Endocrinology, Diabetes and Metabolism and Internal Medicine by the American Board of Internal Medicine, Dr. Steinsapir specializes in the treatment of diabetes, thyroid disease and other metabolic disorders. His day-to-day responsibilities include teaching students and residents at the University of Miami, seeing twenty-five patients per day, conducting clinical trials, and conducting research on diabetes and thyroid disease. 

Following graduation summa cum laude with a medical degree from the University of Chile in 1975, Dr. Steinsapir earned his PhD in Endocrinology with distinction from the Medical College of Georgia in 1988. Subsequently, he completed a clinical endocrine fellowship at the Brigham and Women's Hospital in 1999.  He is a Fellow of the American College of Physicians and Fellow of the American Association of Clinical Endocrinology.

Dr. Steinsapir maintains a membership with The American Association of Clinical Endocrinologists, The American College of Physicians, The American Diabetes Association, The American Society of Internal Medicine, The American Board of Internal Medicine, and The International Society for Clinical Densitometry.

Looking back, Dr. Steinsapir attributes his success to receiving support from his family. His desire to pursue a career in healthcare developed after being inspired by his father, a fellow physician.

In his free time, Dr. Steinsapir enjoys playing chess and traveling.

Considering the future, Dr. Steinsapir hopes to expand his office and to continue teaching.

About the American Health Council:

The American Health Council is the nation’s only organization with a constituency representative of all sectors of the healthcare industry. From the coasts to the heartland, the American Health Council has drawn Affiliates from major metropolitan hubs and small communities. These Affiliates span generations and have reached different stages of their careers — from recent graduates to retirees. More information about the American Health Council and its mission can be found at: http://americanhealthcouncil.org

Additionally, the American Health Council strives to provide recognition and support for those individuals and institutions making the difference in patients’ lives day in and day out. Throughout 2017, the AHC is honoring “America’s Best Doctors and Nurses,” as well as the nation’s best medical universities and hospitals. The American Health Council’s “Best in Medicine” and “Best in Nursing” awards programs honor the individuals and institutions that have contributed significantly to medicine and nursing, as well as the training and education of physicians and nurses. The most current selections for these honors may be viewed here: http://bestinmedicine.org and http://bestinnursing.org.

CONTACT: For more information, please contact:
Elizabeth Moore
American Health Council
Hauppauge, NY United States
Phone: 1-212-390-0214
Email: media@americanhealthcouncil.org

Ads

You May Also Like

TESARO Announces Niraparib Data Presentations at the 2017 SGO Annual Meeting on Women’s Cancer

WALTHAM, Mass., March 12, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...